Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the tumor microenvironment in mature B-cell lymphoid malignancies
Nathan Fowler, Chan Y. Cheah, Randy D. Gascoyne, et al.
Haematologica (2016) Vol. 101, Iss. 5, pp. 531-540
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
Frank Vari, David Arpon, Colm Keane, et al.
Blood (2018) Vol. 131, Iss. 16, pp. 1809-1819
Open Access | Times Cited: 274
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models
Kevin Nishimoto, Taylor Barca, Aruna Azameera, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 79
Burkitt lymphoma
Cristina López, Birgit Burkhardt, John K. C. Chan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 77
Tumor microenvironment as a complex milieu driving cancer progression: a mini review
Zhengrui Li, Jing Li, Xiaolei Bai, et al.
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 16
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W.D. Tobin, Colm Keane, Jay Gunawardana, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 34, pp. 3300-3309
Open Access | Times Cited: 110
Mechanisms of Immune Tolerance in Leukemia and Lymphoma
Emily Curran, James Godfrey, Justin Kline
Trends in Immunology (2017) Vol. 38, Iss. 7, pp. 513-525
Open Access | Times Cited: 94
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells
Veronika Bachanová, Dhifaf Sarhan, Todd E. DeFor, et al.
Cancer Immunology Immunotherapy (2017) Vol. 67, Iss. 3, pp. 483-494
Open Access | Times Cited: 84
Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation
Elena Viganò, Jay Gunawardana, Anja Mottok, et al.
Blood (2018) Vol. 131, Iss. 18, pp. 2036-2046
Open Access | Times Cited: 48
The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
Colm Keane, Joshua W.D. Tobin, Jay Gunawardana, et al.
European Journal Of Haematology (2019) Vol. 103, Iss. 3, pp. 200-207
Open Access | Times Cited: 47
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy
Lukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 9, pp. 1751-1766
Closed Access | Times Cited: 47
In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead?
Carlotta Mattioda, Claudia Voena, Gianluca Ciardelli, et al.
Cells (2025) Vol. 14, Iss. 1, pp. 38-38
Open Access
Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma
Ying Liu, Biping Deng, Bo Hu, et al.
Blood Advances (2021) Vol. 6, Iss. 3, pp. 717-730
Open Access | Times Cited: 32
CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights
Alaa M. Ali, André Goy, Kieron Dunleavy
Blood (2022) Vol. 140, Iss. 13, pp. 1461-1469
Open Access | Times Cited: 19
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
Vaishali Bhardwaj, Stephen M. Ansell
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11
High FCGR2B Expression Can Identify Low-tumor-burden Follicular Lymphoma Patients Who Do Not Require Any Antilymphoma Therapy for a Long Term
Shotaro Watanabe, Hiroki Kato, Tohru Fujiwara, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Prognostic relevance of bone marrow immune cell fractions in newly diagnosed B-cell non-Hodgkin lymphoma patients
Luciana Valvano, Rocchina Vilella, Fiorella D’Auria, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective
Kieron Dunleavy, Thomas G. Gross
Blood (2018) Vol. 132, Iss. 4, pp. 369-375
Open Access | Times Cited: 37
Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies
Kieron Dunleavy
Hematology (2017) Vol. 2017, Iss. 1, pp. 298-303
Open Access | Times Cited: 34
Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
Massimo Granai, Lucia Mundo, Ayse U. Akarca, et al.
Infectious Agents and Cancer (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 29
A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival
Claire Lamaison, Simon Latour, Nelson Hélaine, et al.
Blood Advances (2021) Vol. 5, Iss. 23, pp. 5372-5386
Open Access | Times Cited: 23
Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel
N. Eric Olson, Seamus P. Ragan, David J. Reiss, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 3, pp. 406-418
Open Access | Times Cited: 8
The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies
Sherien M. El‐Daly, Recep Bayraktar, Simone Anfossi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3387-3387
Open Access | Times Cited: 23
Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms
Hao Guo, Jingyi Yang, Haoran Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Peripheral T‐cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK‐negative
Karthik A. Ganapathi, Alina Nicolae, Caoimhe Egan, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1862-1871
Open Access | Times Cited: 2
c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells
Amandine David, Nicolas Arnaud, Magali Fradet, et al.
Haematologica (2017) Vol. 102, Iss. 5, pp. 883-894
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top